Amanda VanSteelandt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amanda VanSteelandt has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Fiona Kouyoumdjian
Ministère de la Santé de l’Ontario, Toronto (Ontario), Canada
6 shared publicationsGrace Yi-Shin Chang
Substance-Related Harms Division, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada
4 shared publicationsJingru Helen Ha
Division des méfaits liés aux substances, Direction générale de la promotion de la santé et de la prévention des maladies chroniques, Agence de la santé publique du Canada, Ottawa (Ontario), Canada
4 shared publicationsKatherine McKenzie
Division des maladies et affections chroniques, Direction générale de la promotion de la santé et de la prévention des maladies chroniques, Agence de la santé publique du Canada, Ottawa (Ontario), Canada
4 shared publicationsShane Randell
Centre for Emergency Preparedness, Public Health Agency of Canada, Ottawa, Ontario, Canada
4 shared publicationsJacqueline Burt
Office of Drug Research and Surveillance, Health Canada, Ottawa, Ontario, Canada
3 shared publications
Latest Publications
- Open Access
Naloxone administration and toxicity signs and symptoms: An observational study using Canadian death investigation data
A toxic drug supply is responsible for a high number of deaths in Canada. Naloxone is a medication that can temporarily reverse opioid toxicity but cannot act on other drug classes. Take-home naloxone is a key public health response to the overdose crisis where people who may witness an overdose are educated on naloxone administration and overdose response. This study aims to investigate signs and substances associated with naloxone administration stratified by opioid contribution to death and substances detected where naloxone was administered but opioids did not contribute to death. This observational study of Canadian coroner and medical examiner files from 2016 to 2017 uses descriptive and chi square analyses to determine what signs were associated with having been administered naloxone among people for whom opioids contributed to death and what substances were associated with naloxone administration among people for whom no opioids were detected or contributed to the death. The study included 1,521 people who died of acute drug toxicity. Naloxone was administered to 45% of those who died and was administered in higher proportions when opioids contributed to death (50%) compared to when opioids did not (35%). Among people for whom opioids contributed to death, having been administered naloxone was associated with expected opioid toxicity signs of snoring/gurgling, altered consciousness, appearing asleep, and being cold. Among people for whom opioids did not contribute to death, detection of opioids or stimulants were significantly associated with naloxone administration. Further investigation into the barriers to naloxone administration should be conducted in order to improve drug toxicity response education.
Open AccessNaloxone administration and toxicity signs and symptoms: An observational study using Canadian death investigation data
A toxic drug supply is responsible for a high number of deaths in Canada. Naloxone is a medication that can temporarily reverse opioid toxicity but cannot act on other drug classes. Take-home naloxone is a key public health response to the overdose crisis where people who may witness an overdose are educated on naloxone administration and overdose response. This study aims to investigate signs and substances associated with naloxone administration stratified by opioid contribution to death and substances detected where naloxone was administered but opioids did not contribute to death. This observational study of Canadian coroner and medical examiner files from 2016 to 2017 uses descriptive and chi square analyses to determine what signs were associated with having been administered naloxone among people for whom opioids contributed to death and what substances were associated with naloxone administration among people for whom no opioids were detected or contributed to the death. The study included 1,521 people who died of acute drug toxicity. Naloxone was administered to 45% of those who died and was administered in higher proportions when opioids contributed to death (50%) compared to when opioids did not (35%). Among people for whom opioids contributed to death, having been administered naloxone was associated with expected opioid toxicity signs of snoring/gurgling, altered consciousness, appearing asleep, and being cold. Among people for whom opioids did not contribute to death, detection of opioids or stimulants were significantly associated with naloxone administration. Further investigation into the barriers to naloxone administration should be conducted in order to improve drug toxicity response education.
- Open Access
- 3 December 2025
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Substances and substance combinations among accidental substance-related acute toxicity deaths (AATDs) in Canada from 2016 to 2017
Background: Canada has seen a rise in substance-related accidental acute toxicity deaths (AATDs) in recent years. Research indicates that fentanyl opioids, non-fentanyl opioids, and stimulants are classes of concern and that multidrug AATDs have increased. However, there is limited information regarding the specific substances involved. This study aims to identify the substances and substance combinations as well as substance classes and substance class combinations most often involved in AATDs across Canada between 2016 and 2017. It also examines variations in substances by year and across sociodemographic, socioeconomic, and geographic factors. Methods: Data were abstracted from the coroner and medical examiner files of all AATDs that occurred across Canada between 2016 and 2017. Top substances and classes detected in or contributing to AATDs were identified based on toxicology reports and cause of death statements. AATDs were stratified by year of death, age, sex, residence community type, neighbourhood income quintile, and province/region to understand variations in the substances contributing to AATDs. Combinations of substances and classes contributing to death were examined with UpSet plots and trends of select substances were visualized over time with ribbon charts. An algorithm was developed to report the source and origin of the substances based on prescription history and scene evidence. Results: Fentanyl, cocaine, alcohol, and methamphetamine were the top substances contributing to the 7,902 AATDs identified between 2016 and 2017 in Canada. While stimulants and opioids were the most common substance classes contributing to AATDs, other classes, including benzodiazepines and acetaminophen also emerged as classes among the top contributors. Between 2016 and 2017, the proportion of AATDs attributable to diacetylmorphine (heroin) per quarter decreased while the proportion of AATDs attributable to carfentanil per quarter increased. AATDs involving more than one substance occurred across all sociodemographic, socioeconomic, and geographic groups. Substances contributing to AATDs more commonly originated from non-pharmaceutical sources than from pharmaceutical sources. Conclusions and impacts: Specific substances and substance combinations contributing to deaths vary over time and geographic areas. Opioids and stimulants are both detected in and contribute to a majority of AATDs, but the substance-related acute toxicity death crisis is complex and attributable to many substance classes. Understanding these differences will allow for targeted substance-related policies, prevention, and harm reduction efforts.
- 3 December 2025
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessSubstances and substance combinations among accidental substance-related acute toxicity deaths (AATDs) in Canada from 2016 to 2017
Background: Canada has seen a rise in substance-related accidental acute toxicity deaths (AATDs) in recent years. Research indicates that fentanyl opioids, non-fentanyl opioids, and stimulants are classes of concern and that multidrug AATDs have increased. However, there is limited information regarding the specific substances involved. This study aims to identify the substances and substance combinations as well as substance classes and substance class combinations most often involved in AATDs across Canada between 2016 and 2017. It also examines variations in substances by year and across sociodemographic, socioeconomic, and geographic factors. Methods: Data were abstracted from the coroner and medical examiner files of all AATDs that occurred across Canada between 2016 and 2017. Top substances and classes detected in or contributing to AATDs were identified based on toxicology reports and cause of death statements. AATDs were stratified by year of death, age, sex, residence community type, neighbourhood income quintile, and province/region to understand variations in the substances contributing to AATDs. Combinations of substances and classes contributing to death were examined with UpSet plots and trends of select substances were visualized over time with ribbon charts. An algorithm was developed to report the source and origin of the substances based on prescription history and scene evidence. Results: Fentanyl, cocaine, alcohol, and methamphetamine were the top substances contributing to the 7,902 AATDs identified between 2016 and 2017 in Canada. While stimulants and opioids were the most common substance classes contributing to AATDs, other classes, including benzodiazepines and acetaminophen also emerged as classes among the top contributors. Between 2016 and 2017, the proportion of AATDs attributable to diacetylmorphine (heroin) per quarter decreased while the proportion of AATDs attributable to carfentanil per quarter increased. AATDs involving more than one substance occurred across all sociodemographic, socioeconomic, and geographic groups. Substances contributing to AATDs more commonly originated from non-pharmaceutical sources than from pharmaceutical sources. Conclusions and impacts: Specific substances and substance combinations contributing to deaths vary over time and geographic areas. Opioids and stimulants are both detected in and contribute to a majority of AATDs, but the substance-related acute toxicity death crisis is complex and attributable to many substance classes. Understanding these differences will allow for targeted substance-related policies, prevention, and harm reduction efforts.
- Open Access
- 10 April 2025
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 11 (1) , e49981
Substance-Related Acute Toxicity Deaths in Canada From 2016 to 2017: Protocol for a Retrospective Chart Review Study of Coroner and Medical Examiner Files
Background: Canada continues to experience a national overdose crisis. While studies are available at the regional, provincial, and territorial levels, detailed national data regarding the burden and context of substance-related acute toxicity deaths are limited, particularly in subpopulations. In response to the overdose crisis, the Public Health Agency of Canada, in collaboration with provincial and territorial ministries of health and chief coroner and chief medical examiner offices, has undertaken a national chart review study. Objective: This study was conducted to describe and compare the characteristics of substance-related acute toxicity deaths that occurred in Canada between 2016 and 2017, including descriptions of those who died, the substances involved, and the circumstances surrounding their deaths. This paper describes the study methodology in detail. Methods: This retrospective, population-based, and cross-sectional study involved the review of coroner and medical examiner files for deaths that met the study case definition. Data were collected on demographic and socioeconomic characteristics, medical and substance use history, proximal circumstances surrounding the death, and toxicology findings using a standardized data collection tool that underwent 2 pilot studies. Data abstractors underwent training and regular intrarater reliability exercises with a fictitious death investigation file. Data quality was assessed based on the consistency of abstractor intrarater reliability scores and the completeness of core variables and variables for key concepts. Data were linked to national datasets to allow for the examination of area-level geographic and socioeconomic characteristics. Descriptive analyses will examine differences across subpopulations and the general Canadian population. Latent class, spatiotemporal, qualitative, and premature death analyses are also planned. Where possible, analyses will be stratified by the manner of death and sex. Results: The study began in the summer of 2018, and abstraction was delayed due to the COVID-19 pandemic. All activities are expected to be completed by early 2025. A total of 9414 coroner and medical examiner files met the study case definition. Most abstractors (25/26, 96%) met the established threshold for consistency throughout abstraction without the need for remedial training. In general, core study variables, including geographic variables and substances contributing to death, had very good availability. Study variables related to the person’s health, history of substance use, and events surrounding the acute toxicity event were available for most records. Socioeconomic variables and variables describing socially constructed identities and potentially traumatic life events were mostly unavailable. Conclusions: This study provides the most detailed national information on substance-related acute toxicity deaths in Canada to date and can serve as a pre–COVID-19 pandemic baseline for assessing the evolution of the overdose crisis. Results can inform policies and programs to address the overdose crisis, the development of common approaches to medicolegal death investigations, and future research activities.
- 10 April 2025
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 11 (1) , e49981
Open AccessSubstance-Related Acute Toxicity Deaths in Canada From 2016 to 2017: Protocol for a Retrospective Chart Review Study of Coroner and Medical Examiner Files
Background: Canada continues to experience a national overdose crisis. While studies are available at the regional, provincial, and territorial levels, detailed national data regarding the burden and context of substance-related acute toxicity deaths are limited, particularly in subpopulations. In response to the overdose crisis, the Public Health Agency of Canada, in collaboration with provincial and territorial ministries of health and chief coroner and chief medical examiner offices, has undertaken a national chart review study. Objective: This study was conducted to describe and compare the characteristics of substance-related acute toxicity deaths that occurred in Canada between 2016 and 2017, including descriptions of those who died, the substances involved, and the circumstances surrounding their deaths. This paper describes the study methodology in detail. Methods: This retrospective, population-based, and cross-sectional study involved the review of coroner and medical examiner files for deaths that met the study case definition. Data were collected on demographic and socioeconomic characteristics, medical and substance use history, proximal circumstances surrounding the death, and toxicology findings using a standardized data collection tool that underwent 2 pilot studies. Data abstractors underwent training and regular intrarater reliability exercises with a fictitious death investigation file. Data quality was assessed based on the consistency of abstractor intrarater reliability scores and the completeness of core variables and variables for key concepts. Data were linked to national datasets to allow for the examination of area-level geographic and socioeconomic characteristics. Descriptive analyses will examine differences across subpopulations and the general Canadian population. Latent class, spatiotemporal, qualitative, and premature death analyses are also planned. Where possible, analyses will be stratified by the manner of death and sex. Results: The study began in the summer of 2018, and abstraction was delayed due to the COVID-19 pandemic. All activities are expected to be completed by early 2025. A total of 9414 coroner and medical examiner files met the study case definition. Most abstractors (25/26, 96%) met the established threshold for consistency throughout abstraction without the need for remedial training. In general, core study variables, including geographic variables and substances contributing to death, had very good availability. Study variables related to the person’s health, history of substance use, and events surrounding the acute toxicity event were available for most records. Socioeconomic variables and variables describing socially constructed identities and potentially traumatic life events were mostly unavailable. Conclusions: This study provides the most detailed national information on substance-related acute toxicity deaths in Canada to date and can serve as a pre–COVID-19 pandemic baseline for assessing the evolution of the overdose crisis. Results can inform policies and programs to address the overdose crisis, the development of common approaches to medicolegal death investigations, and future research activities.
- Open Access
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Promotion de la santé et prévention des maladies chroniques au Canada
- Vol. 44 (7/8) , 353-366
Statut résidentiel et décès accidentels attribuables à une intoxication aiguë liée à une substance au Canada, 2016-2017
Introduction Il existe une relation complexe entre le statut résidentiel et la consommation de substances. En effet, la consommation de substances réduit les perspectives de logement et le fait d’être sans logement augmente les raisons de consommer des substances ainsi que les risques et la stigmatisation qui y sont associés. Méthodologie Dans cette analyse descriptive des personnes sans logement qui ont perdu la vie en raison d’une intoxication aiguë accidentelle liée à une substance au Canada, nous avons utilisé les données relatives aux enquêtes sur les décès tirées d’une étude nationale d’examen des dossiers concernant les décès par intoxication aiguë due à une substance en 2016 et 2017, afin de comparer les facteurs sociodémographiques, les antécédents médicaux, les circonstances du décès et les substances ayant contribué au décès des personnes sans logement et des personnes non identifiées comme sans logement, au moyen du test du khi carré de Pearson. Nous avons comparé le profil démographique des personnes décédées d’une intoxication aiguë aux données du Dénombrement ponctuel coordonné de l’itinérance dans les collectivités canadiennes de 2016 et du Recensement de 2016. Résultats Les personnes sans logement étaient nettement surreprésentées parmi les personnes décédées d’une intoxication aiguë en 2016 et 2017 (8,9 % contre moins de 1 % de la population générale). L’intoxication aiguë ayant entraîné le décès des personnes sans logement a eu lieu plus souvent à l’extérieur (24 %); un opioïde ou un stimulant a plus fréquemment contribué à leur décès (68 % à 82 %; les deux substances ont été responsables de 59 % des décès) et ces personnes avaient plus souvent été libérées d’un établissement correctionnel ou été autorisées à sortir d’un établissement de soins de santé au cours du mois précédant leur décès (7 %). Conclusion Nous présentons plusieurs possibilités de réduire les décès attribuables à une intoxication aiguë chez les personnes sans logement, notamment lors de la prise de contact avec les services de santé et d’autres établissements, par des mesures de soutien à la réduction des méfaits liés à la consommation d’opioïdes et de stimulants ainsi que par la création d’environnements plus sûrs pour les personnes sans logement.
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Promotion de la santé et prévention des maladies chroniques au Canada
- Vol. 44 (7/8) , 353-366
Open AccessStatut résidentiel et décès accidentels attribuables à une intoxication aiguë liée à une substance au Canada, 2016-2017
Introduction Il existe une relation complexe entre le statut résidentiel et la consommation de substances. En effet, la consommation de substances réduit les perspectives de logement et le fait d’être sans logement augmente les raisons de consommer des substances ainsi que les risques et la stigmatisation qui y sont associés. Méthodologie Dans cette analyse descriptive des personnes sans logement qui ont perdu la vie en raison d’une intoxication aiguë accidentelle liée à une substance au Canada, nous avons utilisé les données relatives aux enquêtes sur les décès tirées d’une étude nationale d’examen des dossiers concernant les décès par intoxication aiguë due à une substance en 2016 et 2017, afin de comparer les facteurs sociodémographiques, les antécédents médicaux, les circonstances du décès et les substances ayant contribué au décès des personnes sans logement et des personnes non identifiées comme sans logement, au moyen du test du khi carré de Pearson. Nous avons comparé le profil démographique des personnes décédées d’une intoxication aiguë aux données du Dénombrement ponctuel coordonné de l’itinérance dans les collectivités canadiennes de 2016 et du Recensement de 2016. Résultats Les personnes sans logement étaient nettement surreprésentées parmi les personnes décédées d’une intoxication aiguë en 2016 et 2017 (8,9 % contre moins de 1 % de la population générale). L’intoxication aiguë ayant entraîné le décès des personnes sans logement a eu lieu plus souvent à l’extérieur (24 %); un opioïde ou un stimulant a plus fréquemment contribué à leur décès (68 % à 82 %; les deux substances ont été responsables de 59 % des décès) et ces personnes avaient plus souvent été libérées d’un établissement correctionnel ou été autorisées à sortir d’un établissement de soins de santé au cours du mois précédant leur décès (7 %). Conclusion Nous présentons plusieurs possibilités de réduire les décès attribuables à une intoxication aiguë chez les personnes sans logement, notamment lors de la prise de contact avec les services de santé et d’autres établissements, par des mesures de soutien à la réduction des méfaits liés à la consommation d’opioïdes et de stimulants ainsi que par la création d’environnements plus sûrs pour les personnes sans logement.
- Open Access
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 44 (7/8) , 319-330
Housing status and accidental substance-related acute toxicity deaths in Canada, 2016–2017
Introduction There is a complex relationship between housing status and substance use, where substance use reduces housing opportunities and being unhoused increases reasons to use substances, and the associated risks and stigma. Methods In this descriptive analysis of people without housing who died of accidental substance-related acute toxicity in Canada, we used death investigation data from a national chart review study of substance-related acute toxicity deaths in 2016 and 2017 to compare sociodemographic factors, health histories, circumstances of death and substances contributing to death of people who were unhoused and people not identified as unhoused, using Pearson chi-square test. The demographic distribution of people who died of acute toxicity was compared with the 2016 Nationally Coordinated Point-In-Time Count of Homelessness in Canadian Communities and the 2016 Census. Results People without housing were substantially overrepresented among those who died of acute toxicity in 2016 and 2017 (8.9% versus $lt;1% of the overall population). The acute toxicity event leading to death of people without housing occurred more often in an outdoor setting (24%); an opioid and/or stimulant was identified as contributing to their death more frequently (68%–82%; both contributed in 59% of their deaths); and they were more frequently discharged from an institution in the month before their death (7%). Conclusion We identified several potential opportunities to reduce acute toxicity deaths among people who are unhoused, including during contacts with health care and other institutions, through harm reduction supports for opioid and stimulant use, and by creating safer environments for people without housing.
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 44 (7/8) , 319-330
Open AccessHousing status and accidental substance-related acute toxicity deaths in Canada, 2016–2017
Introduction There is a complex relationship between housing status and substance use, where substance use reduces housing opportunities and being unhoused increases reasons to use substances, and the associated risks and stigma. Methods In this descriptive analysis of people without housing who died of accidental substance-related acute toxicity in Canada, we used death investigation data from a national chart review study of substance-related acute toxicity deaths in 2016 and 2017 to compare sociodemographic factors, health histories, circumstances of death and substances contributing to death of people who were unhoused and people not identified as unhoused, using Pearson chi-square test. The demographic distribution of people who died of acute toxicity was compared with the 2016 Nationally Coordinated Point-In-Time Count of Homelessness in Canadian Communities and the 2016 Census. Results People without housing were substantially overrepresented among those who died of acute toxicity in 2016 and 2017 (8.9% versus $lt;1% of the overall population). The acute toxicity event leading to death of people without housing occurred more often in an outdoor setting (24%); an opioid and/or stimulant was identified as contributing to their death more frequently (68%–82%; both contributed in 59% of their deaths); and they were more frequently discharged from an institution in the month before their death (7%). Conclusion We identified several potential opportunities to reduce acute toxicity deaths among people who are unhoused, including during contacts with health care and other institutions, through harm reduction supports for opioid and stimulant use, and by creating safer environments for people without housing.
- Open Access
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Promotion de la santé et prévention des maladies chroniques au Canada
- Vol. 44 (7/8) , 367-374
Comparaison des caractéristiques des décès accidentels attribuables à une intoxication aiguë due à une substance au Canada aux différents stades de la vie, 2016-2017
Résumé La crise des intoxications aiguës (parfois appelées « surdoses » ou « empoisonnements ») touche la population canadienne à toutes les étapes de vie, que ce soit les jeunes, les adultes ou les aînés.
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Promotion de la santé et prévention des maladies chroniques au Canada
- Vol. 44 (7/8) , 367-374
Open AccessComparaison des caractéristiques des décès accidentels attribuables à une intoxication aiguë due à une substance au Canada aux différents stades de la vie, 2016-2017
Résumé La crise des intoxications aiguës (parfois appelées « surdoses » ou « empoisonnements ») touche la population canadienne à toutes les étapes de vie, que ce soit les jeunes, les adultes ou les aînés.
- Open Access
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 44 (7/8) , 331-337
A comparison of the characteristics of accidental substance-related acute toxicity deaths in Canada across life stages, 2016–2017
The acute toxicity (sometimes called “overdose” or “poisoning”) crisis has affected Canadians from all walks of life and of all ages—children, youth, adults including older adults have died.
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 44 (7/8) , 331-337
Open AccessA comparison of the characteristics of accidental substance-related acute toxicity deaths in Canada across life stages, 2016–2017
The acute toxicity (sometimes called “overdose” or “poisoning”) crisis has affected Canadians from all walks of life and of all ages—children, youth, adults including older adults have died.
- Open Access
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Promotion de la santé et prévention des maladies chroniques au Canada
- Vol. 44 (7/8) , 338-352
La douleur chronique et les décès par intoxication aiguë accidentelle au Canada, 2016-2017
Introduction Dans plusieurs provinces et territoires du Canada, on remarque que, souvent, les personnes qui décèdent d’une intoxication aiguë liée à une substance souffraient aussi de douleur chronique. Cette étude traite de la prévalence de la douleur chronique et des caractéristiques des personnes qui en sont atteintes en utilisant les données d’une étude nationale sur les décès par intoxication aiguë accidentelle. Méthodologie Nous avons réalisé une analyse transversale des décès par intoxication aiguë accidentelle liée à une substance qui ont eu lieu au Canada entre le 1er janvier 2016 et le 31 décembre 2017. Nous avons synthétisé, sous forme d’effectifs et de pourcentages, la prévalence de la douleur ainsi que des problèmes de santé liés à la douleur à partir de l’échantillon global. Nous avons effectué des comparaisons entre les personnes avec antécédents documentés de douleur chronique et les personnes sans antécédents documentés de douleur chronique, sur la base de différentes caractéristiques sociodémographiques, des antécédents médicaux, de facteurs contextuels et des substances consommées. Résultats Au sein de l’échantillon global (N = 7 902), 1 056 (13 %) personnes avaient des antécédents documentés de douleur chronique et 6 366 (81 %) n’en avaient pas. En général, les personnes souffrant de douleur chronique étaient plus âgées (40 ans et plus), n’avaient pas d’emploi et étaient à la retraite ou recevaient des prestations d’invalidité au moment de leur décès. Des antécédents de problèmes de santé mentale, de traumatisme et de chirurgie ou de blessure étaient beaucoup plus fréquents chez les personnes atteintes de douleur chronique. Parmi les substances le plus couramment en cause dans les décès, les opioïdes habituellement prescrits pour soulager la douleur (hydromorphone et oxycodone) ont été détectés plus souvent dans les analyses toxicologiques des personnes avec douleur chronique que dans les analyses des personnes sans douleur chronique. Conclusion Les résultats font ressortir le rôle transversal que jouent la présence concomitante de problèmes de santé et la douleur non traitée, cette dernière risquant d’accroître le risque de décès par intoxication aiguë. Continuer à prioriser la réduction des méfaits et mettre à contribution régulière des patients pour l’évaluation des besoins courants font partie des pistes d’intervention.
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Promotion de la santé et prévention des maladies chroniques au Canada
- Vol. 44 (7/8) , 338-352
Open AccessLa douleur chronique et les décès par intoxication aiguë accidentelle au Canada, 2016-2017
Introduction Dans plusieurs provinces et territoires du Canada, on remarque que, souvent, les personnes qui décèdent d’une intoxication aiguë liée à une substance souffraient aussi de douleur chronique. Cette étude traite de la prévalence de la douleur chronique et des caractéristiques des personnes qui en sont atteintes en utilisant les données d’une étude nationale sur les décès par intoxication aiguë accidentelle. Méthodologie Nous avons réalisé une analyse transversale des décès par intoxication aiguë accidentelle liée à une substance qui ont eu lieu au Canada entre le 1er janvier 2016 et le 31 décembre 2017. Nous avons synthétisé, sous forme d’effectifs et de pourcentages, la prévalence de la douleur ainsi que des problèmes de santé liés à la douleur à partir de l’échantillon global. Nous avons effectué des comparaisons entre les personnes avec antécédents documentés de douleur chronique et les personnes sans antécédents documentés de douleur chronique, sur la base de différentes caractéristiques sociodémographiques, des antécédents médicaux, de facteurs contextuels et des substances consommées. Résultats Au sein de l’échantillon global (N = 7 902), 1 056 (13 %) personnes avaient des antécédents documentés de douleur chronique et 6 366 (81 %) n’en avaient pas. En général, les personnes souffrant de douleur chronique étaient plus âgées (40 ans et plus), n’avaient pas d’emploi et étaient à la retraite ou recevaient des prestations d’invalidité au moment de leur décès. Des antécédents de problèmes de santé mentale, de traumatisme et de chirurgie ou de blessure étaient beaucoup plus fréquents chez les personnes atteintes de douleur chronique. Parmi les substances le plus couramment en cause dans les décès, les opioïdes habituellement prescrits pour soulager la douleur (hydromorphone et oxycodone) ont été détectés plus souvent dans les analyses toxicologiques des personnes avec douleur chronique que dans les analyses des personnes sans douleur chronique. Conclusion Les résultats font ressortir le rôle transversal que jouent la présence concomitante de problèmes de santé et la douleur non traitée, cette dernière risquant d’accroître le risque de décès par intoxication aiguë. Continuer à prioriser la réduction des méfaits et mettre à contribution régulière des patients pour l’évaluation des besoins courants font partie des pistes d’intervention.
- Open Access
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 44 (7/8) , 306-318
Chronic pain and accidental acute toxicity deaths in Canada, 2016–2017
Introduction Multiple Canadian jurisdictions have reported a pattern of chronic pain among people who died from substance-related acute toxicity. This study examined the prevalence and characteristics of those with chronic pain using data from a national study of people who died of accidental acute toxicity. Methods A cross-sectional analysis of accidental substance-related acute toxicity deaths that occurred in Canada between 1 January 2016 and 31 December 2017 was conducted. The prevalence of pain and pain-related conditions were summarized as counts and percentages of the overall sample. Subgroups of people with and without a documented history of chronic pain were compared across sociodemographic characteristics, health history, contextual factors and substances involved. Results From the overall sample (n = 7902), 1056 (13%) people had a history of chronic pain while 6366 (81%) had no documented history. Those with chronic pain tended to be older (40 years and older), unemployed, retired and/or receiving disability supports around the time of death. History of mental health conditions, trauma and surgery or injury was significantly more prevalent among people with chronic pain. Of the substances that most frequently contributed to death, opioids typically prescribed for pain (hydromorphone and oxycodone) were detected in toxicology more often among those with chronic pain than those without. Conclusion Findings underscore the cross-cutting role of multiple comorbidities and unmanaged pain, which could compound the risk of acute toxicity death. Continued prioritization of harm reduction and regular patient engagement to assess ongoing needs are among the various opportunities for intervention.
- 1 August 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 44 (7/8) , 306-318
Open AccessChronic pain and accidental acute toxicity deaths in Canada, 2016–2017
Introduction Multiple Canadian jurisdictions have reported a pattern of chronic pain among people who died from substance-related acute toxicity. This study examined the prevalence and characteristics of those with chronic pain using data from a national study of people who died of accidental acute toxicity. Methods A cross-sectional analysis of accidental substance-related acute toxicity deaths that occurred in Canada between 1 January 2016 and 31 December 2017 was conducted. The prevalence of pain and pain-related conditions were summarized as counts and percentages of the overall sample. Subgroups of people with and without a documented history of chronic pain were compared across sociodemographic characteristics, health history, contextual factors and substances involved. Results From the overall sample (n = 7902), 1056 (13%) people had a history of chronic pain while 6366 (81%) had no documented history. Those with chronic pain tended to be older (40 years and older), unemployed, retired and/or receiving disability supports around the time of death. History of mental health conditions, trauma and surgery or injury was significantly more prevalent among people with chronic pain. Of the substances that most frequently contributed to death, opioids typically prescribed for pain (hydromorphone and oxycodone) were detected in toxicology more often among those with chronic pain than those without. Conclusion Findings underscore the cross-cutting role of multiple comorbidities and unmanaged pain, which could compound the risk of acute toxicity death. Continued prioritization of harm reduction and regular patient engagement to assess ongoing needs are among the various opportunities for intervention.
- Open Access
- 1 March 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 44 (3) , 89-100
Accidental substance-related acute toxicity deaths in older adults in 2016 and 2017: a national chart review study
Introduction Limited research exists on substance-related acute toxicity deaths (ATDs) in older adults (≥60 years) in Canada. This study aims to examine and describe the sociodemographic characteristics, health histories and circumstances of death for accidental ATDs among older adults. Methods Following a retrospective descriptive analysis of all coroner and medical examiner files on accidental substance-related ATDs in older adults in Canada from 2016 to 2017, proportions and mortality rates for coroner and medical examiner data were compared with general population data on older adults from the 2016 Census. Chisquare tests were conducted for categorical variables where possible. Results From 2016 to 2017, there were 705 documented accidental ATDs in older adults. Multiple substances contributed to 61% of these deaths. Fentanyl, cocaine and ethanol (alcohol) were the most common substances contributing to death. Heart disease (33%), chronic pain (27%) and depression (26%) were commonly documented. Approximately 84% of older adults had contact with health care services in the year preceding their death. Only 14% were confirmed as having their deaths witnessed. Conclusion Findings provide insight into the demographic, contextual and medical history factors that may influence substance-related ATDs in older adults and suggest key areas for prevention.
- 1 March 2024
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 44 (3) , 89-100
Open AccessAccidental substance-related acute toxicity deaths in older adults in 2016 and 2017: a national chart review study
Introduction Limited research exists on substance-related acute toxicity deaths (ATDs) in older adults (≥60 years) in Canada. This study aims to examine and describe the sociodemographic characteristics, health histories and circumstances of death for accidental ATDs among older adults. Methods Following a retrospective descriptive analysis of all coroner and medical examiner files on accidental substance-related ATDs in older adults in Canada from 2016 to 2017, proportions and mortality rates for coroner and medical examiner data were compared with general population data on older adults from the 2016 Census. Chisquare tests were conducted for categorical variables where possible. Results From 2016 to 2017, there were 705 documented accidental ATDs in older adults. Multiple substances contributed to 61% of these deaths. Fentanyl, cocaine and ethanol (alcohol) were the most common substances contributing to death. Heart disease (33%), chronic pain (27%) and depression (26%) were commonly documented. Approximately 84% of older adults had contact with health care services in the year preceding their death. Only 14% were confirmed as having their deaths witnessed. Conclusion Findings provide insight into the demographic, contextual and medical history factors that may influence substance-related ATDs in older adults and suggest key areas for prevention.